A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client was interested in assessing current market dynamics, key competitors, generating customer feedback via primary research survey and KOL interviews, and an analysis of the current regulatory landscape with the ultimate go/no-go recommendation to enter the market.

For the full case study including example deliverables, click here:  503B Compounding Pharmacy Market Assessment

Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.